ROLE OF BIOLOGICAL CLOCK MALFUNCTION IN THE PATHOGENESIS OF DIABETES MELLITUS
DOI: 10.22138/2500-0918-2023-20-3-5-17
Yu. V. Bykov
Federal State Budgetary Educational Institution “Stavropol State Medical University”
of the Ministry of Health of the Russian Federation, Stavropol, Russian Federation;
State budgetary healthcare institution of the Stavropol Territory “City Children’s Clinical Hospital named after G.K. Filippsky», Stavropol, Russian Federation
Abstract. Purpose. This paper provides a review of biological clock (BC) malfunction as a possible pathophysiological mechanism underlying the development of type 1 and 2 diabetes mellitus (DM). Objective of the review. A total of 69 scientific papers were found using the Cochrane Library, PubMed, eLibrary.ru and Medscape, and analyzed. The search covered the period from 2012 to 2023 and used the combination of the following keywords: “diabetes mellitus”, “biological clock”, “melatonin”. Results. It covers the main physiological aspects of BC operation and their contribution to the maintenance of the body’s homeostasis. Also discussed are issues related to BC-mediated regulation of glucose and insulin levels. Arguments are provided to corroborate the involvement of BC malfunction in the development of DM through biological rhythm desynchronization, activation of mitochondrial dysfunction, and oxidative stress. Another point of discussion is disrupted melatonin synthesis as a marker of BC malfunction and as a possible trigger of the development of DM. Conclusion. The theory of the involvement of BC malfunction in DM pathogenesis is up-to-date and supported by scientific evidence and therefore needs to be researched and developed further.
Keywords: diabetes mellitus, biological clock, melatonin
There is no conflict of interest.
Contact details of the corresponding author:
Yuri V. Bykov
yubykov@gmail.com
Received 31.08.2023
For citation:
Bykov Yu. V. Role of biological clock malfunction in the pathogenesis of diabetes mellitus. [Online] Vestn. Ural. Med. Akad. Nauki. = Journal of Ural Medical Academic Science. 2023, Vol. 20, no. 3, pp. 5–17. DOI: 10.22138/2500-0918-2023-20-3-5-17 (In Russ)
REFERENCES
1. Onaolapo A.Y., Onaolapo O.J. Circadian dysrhythmia-linked diabetes mellitus: Examining melatonin’s roles in prophylaxis and management. World J Diabetes. 2018; 9(7): 99–114.
2. Bykov Yu.V., Baturin V.A. Cognitive impairment in type 1 diabetes mellitus. Siberian Scientific Medical Journal = Sibirskij nauchnyj medicinskij zhurnal. 2023(a);43(1):4–12. (In Russ.)
3. Bunyatyan N.D., Bukhtiyarova I.P., Drogovoz S.M., Kononenko A.V., Olefir Yu.V., Prokofiev A.B., Proskurina I.A., Goryachev D.V. Influence of human biorhythms on blood glucose concentration and effectiveness of hypoglycemic drugs (review). Chemical and Pharmaceutical journal = Himiko-farmacevticheskij zhurnal. 2017;5:47-50. (In Russ.)
4. Jin С.Y., Yu S.W., Yin J.T.; et al. Corresponding risk factors between cognitive impairment and type 1 diabetes mellitus: A narrative review. Heliyon. 2022;8(8):e10073.
5. Agrawal M., Agrawal A.K. Pathophysiological Association Between Diabetes Mellitus and Alzheimer’s Disease. Cureus. 2022;14(9):e29120.
6. Gupta M., Pandey S., Rumman M.; et al. Molecular mechanisms underlying hyperglycemia associated cognitive decline. IBRO Neurosci Rep. 2022;14:57-63.
7. Vargas-Soria M., García-Alloza M., Corraliza-Gómez M. Effects of diabetes on microglial physiology: a systematic review of in vitro, preclinical and clinical studies. J Neuroinflammation. 2023;20(1):57.
8. Bykov Yu.V. Oxidative stress and diabetic encephalopathy: pathophysiological aspects. Modern problems of science and education = Sovremennye problemy nauki i obrazovaniya. 2022; 6-2. (In Russ.)
9. Bhat M.A., Bhat S.A., Ahmad S.B.; et al. Biochemical profile and genetic polymorphism of MTHFRC677T in risk of type 2 diabetes mellituss. Int J Diabetes Endocrinol. 2017;2:19–25.
10. Potenza M.A., Sgarra L., Desantis V.; et al. Diabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path? Antioxidants (Basel). 2021;10(8):1257.
11. Bykov Yu. V., Baturin V. A. Chronobiological mechanisms in the pathophysiology of type 1 diabetes mellitus in children. Bulletin of NovSU = Vestnik NovGU. 2023(b);2(131):234-241. (In Russ.)
12. Lee J., Ma K., Moulik M., Yechoo V. Untimely oxidative stress in β-cells leads to diabetes — Role of circadian clock in β-cell function. Free Radic Biol Med. 2018;119:69-74.
13. Banday M.Z., Sameer A.S., Nissar S. Pathophysiology of diabetes: An overview. Avicenna J Med. 2020;10(4):174–188.
14. Parameswaran G., Ray D.W. Sleep, circadian rhythms, and type 2 diabetes mellitus. Clin Endocrinol (Oxf). 2022; 96(1): 12–20.
15. Petersmann A., Müller-Wieland D., Müller U.A.; et al. Definition, Classification and Diagnosis of Diabetes Mellitus. Exp. Clin. Endocrinol. Diabetes. 2019;127:S1–S7.
16. Beck J., Greenwood D.A., Blanton L.; et al. (2018). 2017 National standards for diabetes self-management education and support. The Diabetes Educator, 44, 35–50.
17. Javeed N., Matveyenko A.V. Circadian Etiology of Type 2 Diabetes Mellitus. Physiology (Bethesda). 2018;33(2):138-150.
18. Li M.D., Li C.M., Wang Z. The role of circadian clocks in metabolic disease. Yale J Biol Med. 2012;85:387–401.
19. Allada R., Bass J. Circadian mechanisms in medicine. The New England Journal of Medicine. 2021;384(6):550–561.
20. Sridhar G.R., Sanjana N.S. Sleep, circadian dysrhythmia, obesity and diabetes. World J Diabetes. 2016;7(19) 515–522.
21. Bykov Yu.V., Baturin V.A. Violation of adaptive capabilities in children with insulin-dependent diabetes mellitus based on the methodology of assessing time intervals. Bulletin of modern clinical Medicine = Vestnik sovremennoj klinicheskoj mediciny. 2021;5:112–116. (In Russ.)
22. Sankaranarayanan C., Subramanian P. Molecular mechanisms interlinking biological clock and diabetes mellitus: Effective tools for better management. Diabetes Metab Syndr. 2022;16(11):102639.
23. Tian Y., Zhang D. Biological Clock and Inflammatory Bowel Disease Review: From the Standpoint of the Intestinal Barrier. Gastroenterol Res Pract. 2022;2022:2939921.
24. Giebfried J., Lorentz A. Relationship between the Biological Clock and Inflammatory Bowel Disease. Clocks Sleep. 2023;5(2):260-275.
25. Zee P.C., Attarian H., Videnovic A. Circadian rhythm abnormalities. Continuum (Minneap Minn) 2013;19:132–147.
26. Copertaro A., Bracci M. Working against the biological clock: a review for the Occupational Physician Ind Health. 2019;57(5):557-569.
27. Tsvetkova E.S., Romantsova T.I., Runova G.E., Belyaev N.S., Goldschmidt A.E. Influence of shift work schedule on metabolic health indicators. Obesity and metabolism = Ozhirenie i metabolizm. 2019;3:11-19. (In Russ.)
28. Yu Q. Biological clock: the oscillator of gene expression. Sci China Life Sci. 2018;61(1):128-130.
29. Neves A.R., Albuquerque T., Quintela T., Costa D. Circadian rhythm and disease: Relationship, new insights, and future perspectives. J. Cell. Physiol. 2022;237:3239–3256.
30. Gubin D.G., Kolomeychuk S.N. Accuracy of biological clocks, chronotype, health and longevity. Chronomedical journal = Hronomedicinskij zhurnal. 2019;2:14-27. (In Russ.)
31. Chrościcki P., Usarek M., Bryla J. [The role of biological clock in glucose homeostasis]. [Article in Polish]. Postepy Hig Med Dosw (Online). 2013;67:569-83..
32. Fagiani F., Di Marino D., Romagnoli A.; et al. Molecular regulations of circadian rhythm and implications for physiology and diseases. Signal Transduct. Target. Ther. 2022;7:41.
33. Ramkisoensing A., Meijer J.H. Synchronization of Biological Clock Neurons by Light and Peripheral Feedback Systems Promotes Circadian Rhythms and Health. Front Neurol. 2015;6:128.
34. Maiese K. Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways. Expert Rev Clin Pharmacol. 2020;13(1):23-34.
35. Seshadri N., Doucette C.A. Circadian Regulation of the Pancreatic Beta Cell. Endocrinology. 2021;162(9):bqab089.
36. Mohawk J.A., Green C.B., Takahashi J.S. Central and peripheral circadian clocks in mammals. Annu. Rev. Neurosci. 2012;35:445–462.
37. Coomans C.P., Lucassen E.A., Kooijman S.; et al. Plasticity of circadian clocks and consequences for metabolism. Diabetes Obes. Metab. 2015;17(Suppl. S1):65–75.
38. Woller A., Gonze D. Circadian Misalignment and Metabolic Disorders: A Story of Twisted Clocks. Biology (Basel). 2021;10(3):207. DOI
39. Farhud D., Aryan Z. Circadian Rhythm, Lifestyle and Health: A Narrative Review. Iran J Public Health. 2018;47(8):1068-1076.
40. Cox K.H., Takahashi J.S. Circadian clock genes and the transcriptional architecture of the clock mechanism. J. Mol. Endocrinol. 2019;63:R93–R102.
41. Diallo A.B., Coiffard B., Leone M.; et al. For Whom the Clock Ticks: Clinical Chronobiology for Infectious Diseases. Front Immunol. 2020;11:1457.
42. Barandas R., Landgraf D., McCarthy M., Welsh D. Circadian clocks as modulators of metabolic comorbidity in psychiatric disorders. Curr Psychiatry Rep. (2015) 17:98.
43. Yan X., Xu P., Sun X. Circadian rhythm disruptions: A possible link of bipolar disorder and endocrine comorbidities. Front Psychiatry. 2022;13:1065754.
44. Richards J., Gumz M.L. Advances in understanding the peripheral circadian clocks. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2012;26:3602–3613.
45. Perelis M., Marcheva B., Ramsey K.M.; et al. Pancreatic beta cell enhancers regulate rhythmic transcription of genes controlling insulin secretion. Science. 2015;350(6261):aac4250.
46. Fishbein A., Knutson K., Zee P. Circadian disruption and human health. J Clin Invest. (2021) 131:e148286.
47. Panda S. Circadian physiology of metabolism. Science. (2016) 354:1008–15.
48. Nelaeva Yu.V., Rymar O.D., Petrov I.M., Nelaeva A.A., Yuzhakova A.E. The role of individual organization of circadian rhythms in the formation of carbohydrate metabolism disorders. Diabetes mellitus = Saharnyj diabet. 2023;3:224-235. (In Russ.)
49. Eckel-Mahan K., Sassone-Corsi P. Metabolism and the circadian clock converge. Physiol Rev. 2013;93:107–135.
50. Cribbet M.R., Logan R.W., Edwards M.D.; et al. Circadian rhythms and metabolism: from the brain to the gut and back again. Ann N Y Acad Sci. 2016;1385:21–40.
51. Stenvers D.J., Scheer F.A., Schrauwen P.; et al. Circadian clocks and insulin resistance. Nat Rev Endocrinol. 2019;15(2):75-89.
52. Peek C.B., Affinati A.H., Ramsey K.M.; et al. Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science. 2013;342:1243417.
53. Ramsey K.M., Yoshino J., Brace C.S.; et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science. 2009;324:651–654.
54. Wilking M., Ndiaye M., Mukhtar H., Ahmad N. Circadian Rhythm Connections to Oxidative Stress: Implications for Human Health. Antioxid Redox Signal. 2013;19(2):192–208.
55. Ye L., Wu H., Xu W. Deletion of Bmal1 impairs pancreatic Β-cell function via mitochondrial signaling pathway. Biomed. Res. Int. 2020;2020:9803024.
56. Gerber P.A., Rutter G.A. The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus. Antioxid. Redox Signal. 2017;26:501–518.
57. Bykov Yu.V., Baturin V.A. Violation of the biological clock in adolescents with type 1 diabetes mellitus in remission. Zabaikalsky Medical Bulletin = Zabajkal’skij medicinskij vestnik. 2022;4:19-26. (In Russ.)
58. Espino J., Pariente J.A., Rodríguez A.B. Role of melatonin on diabetes-related metabolic disorders World J Diabetes. 2011; 2(6): 82–91. DOI: 10.4239/wjd.v2.i6.82.
59. Golombek D.A., Rosenstein R.E. Physiology of circadian entrainment. Physiol Rev. 2010;90:1063–1102. DOI: 10.1152/physrev.00009.2009.
60. Costes S, Boss M, Thomas AP, Matveyenko AV. Activation of Melatonin Signaling Promotes β-Cell Survival and Function. Mol Endocrinol. 2015;29:682–692. DOI: 10.1210/me.2014-1293.
61. Ladozhskaya-Gapeenko M.S. Shift of circadian rhythms and risk of diabetes mellitus. Forcipe = Forcipe. 2019;1:246. (In Russ.)
62. Sharma S., Singh H., Ahmad N; et al. The role of melatonin in diabetes: therapeutic implications. Arch Endocrinol Metab. 2015;59:391–399. DOI: 10.1590/2359-3997000000098.
63. Agil A., Rosado I., Ruiz R.; Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats. J Pineal Res. 2012;52:203–210. DOI: 10.1111/j.1600-079X.2011.00928.x.
64. Bazwinsky-Wutschke I., Bieseke L., Muhlbauer E., Peschke E. Influence of melatonin receptor signalling on parameters involved in blood glucose regulation. J Pineal Res. 2014;56:82–96. DOI: 10.1111/jpi.12100.
65. Peschke E., Bähr I., Mühlbauer E. Melatonin and pancreatic islets: interrelationships between melatonin, insulin and glucagon. Int J Mol Sci. 2013;14:6981–7015. DOI: 10.3390/ijms14046981.
66. Fonken L.K., Nelson R.J. The /effects of light at night on circadian clocks and metabolism. Endocr Rev. 2014;35:648–670. DOI: 10.1210/er.2013-1051.
67. Hajam Y.A., Rai S., Pandi-Perumal S.R.; et al. Coadministration of melatonin and insulin improves diabetes-induced impairment of rat kidney function. Neuroendocrinology. 2022;112:807–822. DOI: 10.1159/000520280.
68. Hajam Y.A., Rai S. Melatonin and insulin modulates the cellular biochemistry, histoarchitecture and receptor expression during hepatic injury in diabetic rats. Life Sci. 2019;239:117046. DOI: 10.1016/j.lfs.2019.117046.
69. Thomas A.P., Hoang J., Vongbunyong K. et al. Administration of melatonin and metformin prevents deleterious effects of circadian disruption and obesity in male rats. Endocrinology 157: 4720–4731, 2016. DOI: 10.1210/en.2016-1309.
Author
Yuri V. Bykov
Federal State Budgetary Educational Institution “Stavropol State Medical University” of the Ministry of Health of the Russian Federation;
State budgetary healthcare institution of the Stavropol Territory “City Children’s Clinical Hospital named after G.K. Filippsky
Candidate of Medical Sciences, Docent of the Department of Anesthesiology and Intensive Care with a course of additional professional education, anesthesiologist-reanimatologist
yubykov@gmail.com
ORCID ID: https://orcid.org/0000-0003-4705-3823
Stavropol, Russian Federation